Stanfield, Mendelsohn Lead 'Molepeople' for Savage, Blumhouse, and Paramount

Key points

• LaKeith Stanfield and Ben Mendelsohn have been cast in the horror feature 'Molepeople.'
• Rob Savage will direct the film, which is based on a script by Nathan Elston.
• The project is a co-production between Blumhouse Atomic Monster and Paramount Primal, with Paramount managing global distribution.
• The film is scheduled for a theatrical release on August 27, 2027.
• Production is expected to start in the UK at the end of November or in early December 2026.
• The story follows a man who discovers a twisted society in the abandoned tunnels beneath New York City.

Background

Rob Savage is currently in theaters with 'Other Mommy,' which recently debuted with strong box office numbers. Stanfield recently appeared in Boots Riley's 'I Love Boosters' and Amazon's 'Play Dirty,' while Mendelsohn is promoting Casey Affleck's thriller 'Company' at the Venice Film Festival. The announcement was made during a New York Comic Con panel, where Savage also discussed the film's tone, comparing it to classic horror titles like 'The Texas Chain Saw Massacre' and 'The Hills Have Eyes.'

How outlets are covering it

The Hollywood Reporter provided the initial exclusive details on the cast, release date, and production timeline, noting that Stanfield replaces Anthony Ramos in the role. TheWrap confirmed the casting change and highlighted the announcement's timing during a New York Comic Con panel. Dread Central focused on the director's comments regarding the film's horror elements, quoting Savage's description of the movie as being in the vein of classic slasher films. All outlets agree on the core facts regarding the cast, director, and release date, but differ in emphasis: THR and TheWrap focus on the business and casting logistics, while Dread Central highlights the creative direction and genre positioning.

Why it matters

The collaboration between Blumhouse Atomic Monster and the newly formed Paramount Primal signals a significant shift in how major studios are structuring genre filmmaking. The involvement of high-profile actors like Stanfield and Mendelsohn in a horror project indicates a continued trend of mainstream talent crossing over into the genre, potentially broadening the audience for horror films. The move from indie development to a major studio distribution deal also reflects the industry's strategy for leveraging established brands to mitigate risk in theatrical releases.

What to watch

Production is set to begin in the UK in late November or early December 2026. The film is scheduled for a theatrical release on August 27, 2027. Further casting announcements or marketing campaigns may follow as the production phase approaches.